A61K 38/395
Alveolar surfactant peptides
Official title: {Alveolar surfactant peptides; Pulmonary surfactant peptides}
A61K38/395 (Alveolar surfactant peptides) appears on 62 US grants and 113 published applications in this corpus.
Search patents in A61K- Granted patents
- 62
- Published applications
- 113
- Assignees
- 53
- Inventors
- 154
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 3 |
| 2007 | 0 | 2 |
| 2008 | 0 | 4 |
| 2009 | 1 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 3 |
| 2012 | 2 | 4 |
| 2013 | 2 | 7 |
| 2014 | 5 | 6 |
| 2015 | 3 | 4 |
| 2016 | 5 | 5 |
| 2017 | 3 | 4 |
| 2018 | 6 | 9 |
| 2019 | 3 | 4 |
| 2020 | 6 | 25 |
| 2021 | 2 | 6 |
| 2022 | 2 | 1 |
| 2023 | 10 | 7 |
| 2024 | 1 | 4 |
| 2025 | 3 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD5 May 2026US 12,616,741 B2Children's Hospital Medical Center
- Methods and compositions comprising surfactant protein D (SP-D)9 Dec 2025US 12,491,234 B2Airway Therapeutics, Inc.
- Systems and methods for characterizing surfactant protein D (SP-D) oligomers12 Aug 2025US 12,385,894 B2Airway Therapeutics, Inc.
- Nanocarriers for lung inflammation therapy11 Feb 2025US 12,221,471 B2Ohio State Innovation Foundation
- Compositions and methods for administering PPARγ agonists, surfactant peptides and phospholipids9 Apr 2024US 11,951,158 B2Lindquist Institute for Biomedical Innovation At Harbor-Ucla Medical Center
- Methods for Treating Premature Newborn Infants by Administration of Recombinant Human Surfactant Protein D (rhSP-D)20 Aug 2026US 2026/0240946 A1Airway Therapeutics, Inc.
- Virus polypeptide-protein subunit combination vaccine based on dna nanotechnology, and preparation method therefor and use thereof29 Jan 2026US 2026/0027198 A1
- Surfactant Formulations for Inhalation21 Aug 2025US 2025/0262150 A1Merz Pharmaceuticals, LLC
- Novel application of human airway surfactant, bpifa1, as prophylactic antiviral against respiratory syncytial virus (rsv)10 Jul 2025US 2025/0222075 A1Sanford Burnham Prebys Medical Discovery Institute
- Method and pharmaceutical composition for treating chronic obstructive pulmonary disease15 May 2025US 2025/0152676 A1
Most cited
By later US patents
- Projection exposure apparatus correcting tilt of telecentricity54US 5,739,899 ANikon Corporation · 1998
- Antibody-SN-38 immunoconjugates with a CL2A linker17US 9,629,926 B2Immunomedics, Inc. · 2017
- Antibody-SN-38 immunoconjugates with a CL2A linker16US 9,375,489 B2Immunomedics, Inc. · 2016
- Surfactant and pharmaceutical compositions containing same12US 4,603,124 ATokyo Tanabe Company Limited · 1986
- Compositions and methods for treating cancer11US 10,682,390 B2Biokine Therapeutics Ltd. · 2020